Intraday MarketsStock report · TXG · 10x Genomics, Inc. · Nov 1, 2026
Intraday Markets
Home › Stocks › TXG

TXG Stock: Price, Earnings History and SEC Filings

10x Genomics, Inc. (TXG) last traded at $70.11, down 14.03% on the latest session and down 22.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.14 against an analyst estimate of $-0.23, a beat of 39.1%.

$70.11 -14.03%
1 month-22.41%
52-week high$102.81
52-week low$12.80
Volume5.22M
ExchangeNasdaqGS

Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.

TXG earnings history

QuarterReportedEPSEstimateSurprise
Jun 2026Aug 6, 2026$-0.14$-0.23+39.13%
Mar 2026May 7, 2026$-0.10$-0.29+65.52%
Dec 2025Feb 12, 2026$-0.13$-0.19+31.58%
Sep 2025Nov 6, 2025$-0.22$-0.27+18.52%

TXG beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.

Latest SEC filings for TXG

SEC filing data is not available right now. You can search for TXG on SEC EDGAR.

TXG news

About 10x Genomics, Inc.

10x Genomics, Inc. (TXG) is a US-listed public company on Nasdaq.

Open the live terminal

Related stocks

NVDAAAPLMSFTGOOGLAMZNMETATSLAAVGOAll stocks
intradaymarkets.com · Information only, not investment advice · Data from public sources and may be delayed